Brolucizumab Use in Treatment Resistant Neovascular Age Related Macular Degeneration (nAMD)

被引：0
|
作者：
Shortell, Justin [1 ]
Hill, Christine [2 ]
Thomas, Claire [3 ]
Peck, Travis [1 ]
Melamud, Alexander [1 ]
机构：
[1] MedStar Georgetown Univ Hosp, Ophthalmol, Washington, DC USA
[2] Med Univ South Carolina, Ophthalmol, Charleston, SC USA
[3] Univ Virginia, Charlottesville, VA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Brolucizumab: an evolution in treatment for neovascular age-related macular degeneration
    Ong, Ee Lin
    Spooner, Kimberly
    Hong, Thomas
    Chang, Andrew
    EXPERT REVIEW OF OPHTHALMOLOGY, 2020, 15 (02) : 71 - 81
  • [2] Brolucizumab treatment for pigment epithelial detachment in treatment-resistant neovascular age related macular degeneration
    Chen, Lifei
    Chu, Eugenia
    Hong, Thomas
    Ham, Yeji
    Chang, Andrew
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 50 (08): : 961 - 961
  • [3] Cost-effectiveness analysis of brolucizumab versus aflibercept for the treatment of neovascular age-related macular degeneration (nAMD) in Italy
    Nicola Ferrante
    Daniela Ritrovato
    Rossella Bitonti
    Gianluca Furneri
    BMC Health Services Research, 22
  • [4] Cost-effectiveness analysis of brolucizumab versus aflibercept for the treatment of neovascular age-related macular degeneration (nAMD) in Italy
    Ferrante, Nicola
    Ritrovato, Daniela
    Bitonti, Rossella
    Furneri, Gianluca
    BMC HEALTH SERVICES RESEARCH, 2022, 22 (01)
  • [5] Brolucizumab: evidence to date in the treatment of neovascular age-related macular degeneration
    Yannuzzi, Nicolas A.
    Freund, K. Bailey
    CLINICAL OPHTHALMOLOGY, 2019, 13 : 1323 - 1329
  • [6] Early Experience With Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration
    Enriquez, Ana Bety
    Baumal, Caroline R.
    Crane, Ashley M.
    Witkin, Andre J.
    Lally, David R.
    Liang, Michelle C.
    Enriquez, Jose Ramon
    Eichenbaum, David A.
    JAMA OPHTHALMOLOGY, 2021, 139 (04) : 441 - 448
  • [7] Neovascular Age-Related Macular Degeneration (nAMD): A Review of Emerging Treatment Options
    Tan, Colin S.
    Ngo, Wei Kiong
    Chay, Isaac W.
    Ting, Dominic S.
    Sadda, SriniVas R.
    CLINICAL OPHTHALMOLOGY, 2022, 16 : 917 - 933
  • [8] Brolucizumab for Neovascular Age-Related Macular Degeneration (BEL Study)
    Van Cleemput, Liesbeth
    Peeters, Freya
    Jacob, Julie
    CLINICAL OPHTHALMOLOGY, 2023, 17 : 1077 - 1085
  • [9] NEOVASCULAR AGE RELATED MACULAR DEGENERATION (NAMD): THE EFFECT OF AFLIBERCEPT TREATMENT ON CHOROIDAL THICKNESS IN REFRACTORY NAMD PATIENTS
    Wijeyakumar, Wijeyanthy
    Syed, Adil
    Hong, Thomas
    Broadhead, Geoffrey K.
    Zhu, Meidong
    Chang, Andrew A.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 42 : 124 - 125
  • [10] Switching from aflibercept to brolucizumab for the treatment of refractory neovascular age-related macular degeneration
    Hikaru Ota
    Jun Takeuchi
    Yuyako Nakano
    Etsuyo Horiguchi
    Yosuke Taki
    Yasuki Ito
    Hiroko Terasaki
    Koji M. Nishiguchi
    Keiko Kataoka
    Japanese Journal of Ophthalmology, 2022, 66 : 278 - 284
12345